SBI Securities’s Microbot Medical MBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.52K Buy
2,832
+101
+4% +$206 ﹤0.01% 2127
2026
Q1
$6.58K Buy
2,731
+100
+4% +$223 ﹤0.01% 1906
2025
Q4
$5.26K Sell
2,631
-940
-26% -$2.23K ﹤0.01% 1997
2025
Q3
$10.9K Sell
3,571
-2,155
-38% -$6.72K ﹤0.01% 1736
2025
Q2
$14.4K Sell
5,726
-180
-3% -$431 ﹤0.01% 1536
2025
Q1
$8.92K Buy
5,906
+2,943
+99% +$5.2K ﹤0.01% 1653
2024
Q4
$3.32K Buy
+2,963
New +$2.9K ﹤0.01% 2086

Other funds holding MBOT

SBI Securities's MBOT Position: Q2 2026 in Review

SBI Securities increased its Microbot Medical (MBOT) stake by 3.7% in Q2 2026, buying an estimated $206 and bringing the position to 2,832 shares worth $5.52K. The position accounts for ﹤0.01% of the portfolio, ranked #2127.

SBI Securities first reported a position in MBOT in Q4 2024 and has held it in 7 quarters since. The position peaked at $14.4K in Q2 2025. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • SBI Securities held 2,832 shares of Microbot Medical worth $5.52K as of Q2 2026.
  • SBI Securities bought 101 Microbot Medical shares in Q2 2026, an estimated $206.
  • Microbot Medical made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2127 holding.
  • SBI Securities first reported a position in Microbot Medical in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Microbot Medical position peaked at $14.4K in Q2 2025.
  • 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.